Iradimed (NASDAQ:IRMD) Updates FY 2024 Earnings Guidance
Iradimed (NASDAQ:IRMD – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 1.640-1.670 for the period, compared to the consensus earnings per share estimate of 1.560. The company issued revenue guidance of $72.7 million-$73.1 million, compared to the consensus revenue estimate of $72.6 million. Iradimed […]
More Stories
Colts Quarterback Anthony Richardson to Miss Minicamp Over Shoulder Pain
By John Rigolizzo Indianapolis Colts head coach Shane Steichen said on Thursday that quarterback Anthony Richardson experienced pain in his...
US Adds 562,000 Millionaires as Global Wealth Climbs, Capgemini Finds
By Chase Smith The United States produced more new millionaires than any other country in 2024, helping lift the global...
Trump Signs Orders on Deregulating Flying Cars, Supersonic Flight
By Jacob Burg President Donald Trump signed executive orders on June 6 to deregulate and open research and development into...
Heck Capital Advisors LLC Purchases New Holdings in NVIDIA Co. (NASDAQ:NVDA)
Heck Capital Advisors LLC purchased a new stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) in the fourth quarter, according...
NVIDIA Co. (NASDAQ:NVDA) Stake Increased by Azzad Asset Management Inc. ADV
Azzad Asset Management Inc. ADV grew its stake in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 0.5% during...
Fidelity D & D Bancorp Inc. Cuts Holdings in NVIDIA Co. (NASDAQ:NVDA)
Fidelity D & D Bancorp Inc. reduced its holdings in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 5.5%...